| Yang, Zhi gang |
NCT05000372: 68Ga-grazytracer PET/CT of Tumor Responses to Immunotherapy |
|
|
| Completed | 1/2 | 24 | RoW | 68Ga-grazytracer | Peking University Cancer Hospital & Institute, Peking University Health Science Center | Cancer | 05/24 | 05/24 | | |
NCT06081686: Study of [177Lu] Lu-XT033 Injection in Patients With Metastatic Prostate Cancer |
|
|
| Recruiting | 1/2 | 32 | RoW | Phase I:[177Lu]Lu-XT033 Injection, Phase II:[177Lu]Lu-XT033 Injection | Sinotau Pharmaceutical Group | Prostate Cancer | 12/25 | 12/25 | | |
ZIRDOSE-CP, NCT05861778: Evaluation of 89Zr-TLX250 PET/CT in Chinese Patients With Indeterminate Renal Masses or Suspected Recurrent Renal Clear Cell Carcinoma |
|
|
| Completed | 1 | 10 | RoW | 89Zr-Girentuximab, 89Zr-DFO-girentuximab, 89Zr-TLX250, TLX250CDx | Telix International Pty Ltd, Grand Pharmaceutical (China) Co., Ltd. | Clear Cell Renal Cell Carcinoma, Suspected Recurrent Renal Clear Cell Carcinoma, Recurrent Renal Cell Cancer | 11/23 | 11/23 | | |
| Recruiting | 1 | 20 | RoW | 68Ga-ICAM-1pep, 68Ga-CD54pep | Peking University Cancer Hospital & Institute, Peking University Health Science Center | Cancer | 12/25 | 12/25 | | |
NCT05985278: Clinical Application of Lutetium [177Lu]-Catalase in Tumor Radionuclide Therapy |
|
|
| Recruiting | 1 | 10 | RoW | [ Lu-177]-Catalase | Peking University Cancer Hospital & Institute | Advanced Malignant Neoplasm | 06/26 | 06/26 | | |
NCT04367948: Positron Nuclide Labeled NOTA-FAPI PET Study in Lymphoma |
|
|
| Not yet recruiting | N/A | 200 | RoW | 18F-FDG and 68Ga-NOTA-FAPI04 PET/CT, 18F-FDG and 18F-NOTA-FAPI04 PET/CT | Beijing Cancer Hospital | Tumor, Solid, Positron-Emission Tomography, Lymphoma | 12/21 | 12/22 | | |
| Recruiting | N/A | 120 | RoW | | Beijing Cancer Hospital | Positron-Emission Tomography, Magnetic Resonance Imaging | 12/21 | 02/22 | | |
NCT04750772: Positron Nuclide Labeled DOTA-FAPI PET Study in Colocrectal Cancer |
|
|
| Recruiting | N/A | 60 | RoW | 18F-FDG and 68Ga-DOTA-FAPI04 PET/CT, 18F-FDG and 18F-DOTA-FAPI04 PET/CT | Beijing Cancer Hospital | Tumor, Solid, Positron-Emission Tomography, Colorectal Cancer | 12/22 | 01/23 | | |
NCT04880798: Effect of Thyrotropin Level on Iodine Uptake in Metastatic Differentiated Thyroid Cancer |
|
|
| Recruiting | N/A | 10 | RoW | 124I PET/CT | Peking Union Medical College Hospital, Beijing Cancer Hospital | Differentiated Thyroid Cancer | 12/22 | 12/22 | | |
NCT05390632: Head-to-head Comparison Between [18F]-FDG PET/CT and PET/MRI in Lymphomas |
|
|
| Recruiting | N/A | 100 | RoW | | Peking University Cancer Hospital & Institute | PET/MRI | 04/23 | 12/23 | | |
NCT04693169: [Al18F]PSMA137 PET/CT Imaging for PSMA-Positive Cancer Patients |
|
|
| Active, not recruiting | N/A | 20 | RoW | 11C-Choline, 11C-CH | Peking University Cancer Hospital & Institute | Prostate Cancer | 06/24 | 12/24 | | |
NCT05411250: Early Diagnosis of Therapy-associated Cardiotoxicity Basing on PET/CT in Lymphoma |
|
|
| Not yet recruiting | N/A | 40 | NA | | Beijing Cancer Hospital | Positron-Emission Tomography | 05/23 | 07/23 | | |
